The Hydration Pharmaceuticals Co (ASX:HPC) EV-to-EBITDA : -0.52 (As of Jun. 24, 2024)

The Hydration Pharmaceuticals Co EV-to-EBITDA Chart

Competitive Comparison of The Hydration Pharmaceuticals Co's EV-to-EBITDA

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Hydration Pharmaceuticals Co's EV-to-EBITDA Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's EV-to-EBITDA falls into.

The Hydration Pharmaceuticals Co EV-to-EBITDA Calculation

The Hydration Pharmaceuticals Co's EV-to-EBITDA for today is calculated as:

The Hydration Pharmaceuticals Co's current Enterprise Value is A$5.82 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-11.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co  (ASX:HPC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

The Hydration Pharmaceuticals Co's PE Ratio for today is calculated as:

The Hydration Pharmaceuticals Co's share price for today is A$0.01.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

The Hydration Pharmaceuticals Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of The Hydration Pharmaceuticals Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

The Hydration Pharmaceuticals Co (ASX:HPC) Business Description